ICL Group Ltd Profile Avatar - Palmy Investing

ICL Group Ltd

ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Innovative Ag Solutions (IAS). The Industrial Products se…
Agricultural Inputs
IL, Tel Aviv [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 43% Somewhat Weak
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 0% Bad
Per Share Metrics 0% Bad
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 3.94 25.90 24.92
Graham Fair Price 27.42 2.90 2.28
PEG -44.42 0.30 -0.53
Price/Book 6.39 1.20 1.13
Price/Cash Flow 39.04 51.66 37.15
Prices/Earnings -34.72 15.73 24.10
Price/Sales 9.87 3.99 3.63
Price/FCF 39.04 51.66 37.15
Naive Interpretation member
01 - Valuation · Somewhat Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -3.12 0.32 0.33
Operating Margin 6.31 0.12 0.11
ROA 64.82 < 0.005 < 0.005
ROE 0.01 0.02 62.99
ROIC 0.02 0.02 7.57
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.07 0.03 97.68
Dividends QOQ -0.17 -0.10 39.70
EBIT QOQ -0.14 0.03 -79.98
EPS QOQ -0.45 0.53 17.44
FCF QOQ -0.20 -0.24 -21.14
Revenue QOQ -0.04 -0.03 24.97
Naive Interpretation member
03 - Financial Growth · Balanced
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 127.79 124.52 -2.56
Days Sales Outstanding (DSO) 81.13 77.38 -4.61
Inventory Turnover 0.70 0.72 2.63
Debt/Capitalization 0.30 0.30 0.72
Quick Ratio 0.84 0.81 -3.29
Naive Interpretation member
04 - Leverage & Liquidity · Bad
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 4.44 4.43 -0.19
Cash 0.46 0.37 -18.31
Capex -0.21 -0.11 46.41
Free Cash Flow 0.13 0.10 -23.63
Revenue 1.38 1.33 -3.35
Naive Interpretation member
05 - Per Share Metrics · Bad
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.53 1.60 4.71
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 6.43 6.12 -4.83
Naive Interpretation Member
06 - Financial Health · Weak
End of ICL's Analysis
CIK: 941221 CUSIP: M53213100 ISIN: IL0002810146 LEI: - UEI: -
Secondary Listings
ICL has no secondary listings inside our databases.